New 14-Valent Pneumococcal Vaccine Shows Strong Safety and Immune Response in Indian Infants
A phase IV trial in Indian infants and toddlers found the WHO-prequalified 14-valent pneumococcal conjugate vaccine PNEUBEVAX 14 was well ...
A phase IV trial in Indian infants and toddlers found the WHO-prequalified 14-valent pneumococcal conjugate vaccine PNEUBEVAX 14 was well ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine